Drug
Ontamalimab clinical trials
Also written PF-00547659 and SHP647.
- studies test it
- 12
- open now
- 0
- in phase 3
- 7
- first study started
- 2011
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
12 studies that test it; most in 2018 (5)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Studies
Open first, then newest update. How each study uses ontamalimab is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4TerminatedPhase 1TakedaNCT07052682Written as Ontamalimab
- A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)CompletedPhase 3ShireNCT03283085Written as 25 mg Ontamalimab
- Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)TerminatedPhase 3ShireNCT03627091Written as Ontamalimab
- An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative ColitisCompletedPhase 3ShireNCT03290781Written as Ontamalimab
- Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTerminatedPhase 3ShireNCT03259334Written as Ontamalimab
- A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative ColitisCompletedPhase 2ShireNCT01620255Written as PF-00547659 SC Injection
- A Study To Monitor Long-Term Treatment With PF-00547659CompletedPhase 2ShireNCT01298492Written as PF-00547659
- Long-Term Safety Of PF-00547659 In Ulcerative ColitisCompletedPhase 2ShireNCT01771809Written as 75mg SHP647 (PF-00547659)
- Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's DiseaseCompletedPhase 2ShireNCT01276509Written as PF-00547659 SC injection
- Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)TerminatedPhase 3ShireNCT03566823Written as Ontamalimab
- Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)TerminatedPhase 3ShireNCT03559517Written as Ontamalimab
- Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTerminatedPhase 3ShireNCT03259308Written as Ontamalimab
Codes
What other systems call ontamalimab · ClinicalTrials.gg INT000217
- MeSH (NLM) C000597368ontamalimabOne source NLM
- UNII (FDA) 6LGI7RV4PBONTAMALIMABConfirmed FDA, NLM
- NCI Thesaurus C166947OntamalimabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000597368 | ontamalimab | One source NLM |
| UNII (FDA) | 6LGI7RV4PB | ONTAMALIMAB | Confirmed FDA, NLM |
| NCI Thesaurus | C166947 | Ontamalimab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.